Walleye Trading Advisors »

Design Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $960k 362k 2.65
2023-09-30 $882k 374k 2.36
2023-06-30 $70k 11k 6.30
2022-12-31 $110k 11k 10.26

More positions owned by Walleye Trading Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon Put Option (AMZN)
Tesla Motors Put Option (TSLA)
Meta Platforms Cl A Call Option (META)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Select Sector Spdr Tr Financial Call Option (XLF)
Palo Alto Networks Call Option (PANW)

View all positions for Walleye Trading Advisors

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Citadel Advisors
Baker Bros. Advisors
Tang Capital Management
Almitas Capital
Goldman Sachs Group
Vanguard Group
BML Capital Management
Two Sigma Advisers
Jacobs Levy Equity Management
Two Sigma Investments
Millennium Management
Walleye Trading Advisors
Assenagon Asset Management

View all funds holding Design Therapeutics